Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does VILANTEROL TRIFENATATE Cause Hyperphosphataemia? 75 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 75 reports of Hyperphosphataemia have been filed in association with VILANTEROL TRIFENATATE. This represents 19.1% of all adverse event reports for VILANTEROL TRIFENATATE.

75
Reports of Hyperphosphataemia with VILANTEROL TRIFENATATE
19.1%
of all VILANTEROL TRIFENATATE reports
75
Deaths
71
Hospitalizations

How Dangerous Is Hyperphosphataemia From VILANTEROL TRIFENATATE?

Of the 75 reports, 75 (100.0%) resulted in death, 71 (94.7%) required hospitalization, and 67 (89.3%) were considered life-threatening.

Is Hyperphosphataemia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for VILANTEROL TRIFENATATE. However, 75 reports have been filed with the FAERS database.

What Other Side Effects Does VILANTEROL TRIFENATATE Cause?

Abdominal pain (170) Appendicitis (169) Ascites (169) Abdominal distension (168) Appendicolith (168) Hyponatraemia (167) Cardiogenic shock (165) General physical health deterioration (165) Nausea (165) Stress (164)

What Other Drugs Cause Hyperphosphataemia?

ALLOPURINOL (139) LANSOPRAZOLE (138) ACETAMINOPHEN (132) SEVELAMER (129) ONDANSETRON (127) CALCITRIOL (125) IPRATROPIUM (123) ALBUTEROL (122) METRONIDAZOLE (120) HYDROMORPHONE (118)

Which VILANTEROL TRIFENATATE Alternatives Have Lower Hyperphosphataemia Risk?

VILANTEROL TRIFENATATE vs VILAZODONE VILANTEROL TRIFENATATE vs VILDAGLIPTIN VILANTEROL TRIFENATATE vs VILOXAZINE VILANTEROL TRIFENATATE vs VIMPAT VILANTEROL TRIFENATATE vs VIMSELTINIB

Related Pages

VILANTEROL TRIFENATATE Full Profile All Hyperphosphataemia Reports All Drugs Causing Hyperphosphataemia VILANTEROL TRIFENATATE Demographics